Company profile for Incannex Healthcare

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We develop targeted and scientifically validated fixed-dose combinations of synthetic cannabinoid and psychedelic agents, applying proprietary insights in an effort to create long term value for our patients and shareholders. We focus on clinical indications that we believe represent unmet or inadequately addressed medical needs and also represent compelling commercial opportunities.We are pursuing FDA registration and marketi...
We develop targeted and scientifically validated fixed-dose combinations of synthetic cannabinoid and psychedelic agents, applying proprietary insights in an effort to create long term value for our patients and shareholders. We focus on clinical indications that we believe represent unmet or inadequately addressed medical needs and also represent compelling commercial opportunities.We are pursuing FDA registration and marketing approval for each product and therapy under development.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
Level 39, Rialto South Tower, 525 Collins Street, Melbourne VIC 3000
Telephone
Telephone
+61 (0) 422 180 317
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.nasdaq.com/press-release/incannex-announces-positive-topline-results-from-phase-2-psi-gad1-clinical-trial-of

NASDAQ
28 Feb 2024
Fortrea inks deal with Incannex for sleep apnea drug trial
Fortrea inks deal with Incannex for sleep apnea drug trial

27 Jul 2023

// Joseph Keenan FIERCE BIOTECH

https://www.fiercebiotech.com/cro/fortrea-inks-deal-australias-incannex-sleep-apnea-drug-trial

Joseph Keenan FIERCE BIOTECH
27 Jul 2023

https://www.contractpharma.com/contents/view_breaking-news/2022-11-30/incannex-engages-eurofins-to-manufacture-topical-therapeutic-renecann/?widget=listSection

CONTRACTPHARMA
30 Nov 2022

https://www.contractpharma.com/contents/view_breaking-news/2022-11-28/incannex-eurofins-enter-development-mfg-pact-for-addiction-disorder-meds/9769

CONTRACT PHARMA
28 Nov 2022

https://smallcaps.com.au/incannex-healthcare-manufacture-patented-medicated-chewable-anti-addiction-products/

SMALLCAPS
25 Nov 2022

https://www.proactiveinvestors.com.au/companies/news/988901/incannex-healthcare-partners-with-r-d-organisation-curia-to-scale-up-manufacture-of-drug-targeting-traumatic-brain-injury-988901.html

PROACTIVEINVESTORS
02 Aug 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty